跳至主要内容
临床试验/CTRI/2021/01/030473
CTRI/2021/01/030473已完成未知

Development and validation of a self-administered Diabetes Drug Discontinuation (DDD) questionnaire to evaluate prevalence of treatment discontinuation among type 2 diabetes mellitus patients - Diabetes Drug Discontinuation (DDD) Study

ucknow Diabetes Study Society0 个研究点目标入组 673 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
673

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • a)Diabetes patient who has received pharmacological (allopathic) treatment for more than one month at any time since diagnosis of diabetes, as per ADA guidelines.
  • b)Patientâ??s age at the time of giving consent should be > 18 years
  • c)Willing to accept & sign informed consent before data collection / documentation.

排除标准

  • a)Patient on alternative medicine only.
  • b)Recent acute illness within one month (before the date of enrolling in the present study) requiring hospitalization.
  • c)Illiterate persons. Not able to understand and comply with instructions.
  • d)Patients unable to do self-care, self-administration of medication or have poor cognitive functions.

研究者

发起方
ucknow Diabetes Study Society

相似试验